• Building B270, Babraham Research Campus, Cambridge CB22 3AT
  • Call us on +44 (0) 1223 804075

Nemesis Bioscience Ltd announced today that it had reached an agreement on terms for a two-year research collaboration with Shionogi & Co. Ltd. to further develop Nemesis Transmid Technology© for the treatment and/or prevention of hard-to-treat respiratory infections caused by Pseudomonas aeruginosa. The collaboration will leverage the innovative science and technology platforms of both parties

Nemesis Bioscience Ltd (Cambridge, UK) announced today that it has received a funding award from the UK’s innovation agency, Innovate UK. The Smart Award will be used to develop and protect a novel method for the delivery of polynucleotides, including therapeutics, into bacteria. Nemesis Bioscience Ltd has invented, developed and protected a family of novel biological